Information Library

Results for: Capital - Phase II/III

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Intarcia and Quintiles Finalize Innovative Alliance

    Press Release — December 13, 2011 – To speed development of a potential ground-breaking therapy for Type 2 diabetes – Intarcia Therapeutics, Inc., and Quintiles announced the signing of definitive agreements making Quintiles a financial and strategic partner for the global clinical development of Intarcia’s ITCA 650 (DUROS® continuous subcutaneous delivery of exenatide).

  • Quintiles Launches China CRO, Kun Tuo

    Press Release — December 13, 2011 – Further deepening its commitment to China, Quintiles announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China.

  • QUINTILES PARTNERS WITH THE SEOUL NATIONAL UNIVERSITY HOSPITAL

    Press Release — October 6, 2010 – Quintiles celebrates its 10th year anniversary in South Korea by announcing a strategic alliance with the Seoul National University Hospital (SNUH) as part of its unique Prime Site program.

  • Targeting Oncology

    Brochure — June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Eric Siemers, MD

    Hear from the Experts — May 20, 2010
    Eric Siemers, MD Medical Director, Alzheimer’s Disease Eli Lilly Eric Siemers, M.D. is Medical Director of the Alzheimer’s Disease Team at Eli Lilly

  • Emerging Biopharma Service Fact Sheet

    Brochure — May 4, 2010
    Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies.

  • Mapping the Future in Oncology Drug Development

    Hear from the Experts — March 29, 2010
    A world-renowned, multidisciplinary panel of experts to investigate challenges in, and propose strategies to enhance, oncology drug development.

  • PharmAsia News Article Reprint

    Media Coverage — March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • Hepatitis B Vaccine-Successful Study Strategy in Asia

    Case Study — November 9, 2009
    Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia.

  • Coordinating Safety Across Functions and Phases

    Case Study — November 3, 2009
    Facing significant challenges with clinical and post-marketing safety, a customer needed an ally who could provide a full range of safety and risk management solutions.

Page 1 of 2 (12 results)

Subscribe to Email Based on Your Interests

Set preferences